Nucleoporin 62 and Ca2+/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleoporin 62 and Ca2+/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
Authors
Keywords
-
Journal
PROSTATE
Volume 76, Issue 3, Pages 294-306
Publisher
Wiley
Online
2015-11-10
DOI
10.1002/pros.23121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression
- (2012) Loukia G. Karacosta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology
- (2012) Luigi Racioppi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer
- (2012) Takashi Shima et al. PROSTATE
- Cancer biology and the nuclear envelope: A convoluted relationship
- (2012) Jose I. de las Heras et al. SEMINARS IN CANCER BIOLOGY
- The role of Nup98 in transcription regulation in healthy and diseased cells
- (2012) Tobias M. Franks et al. TRENDS IN CELL BIOLOGY
- Interchromosomal clustering of active genes at the nuclear pore complex
- (2012) Donna G. Brickner et al. Nucleus
- Frequencies of different nuclear morphological features in prostate adenocarcinoma
- (2011) Farhat Rashid et al. Annals of Diagnostic Pathology
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Post-translational modification of the androgen receptor
- (2011) Daniel Gioeli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
- (2011) Kristin R. Lamont et al. MOLECULAR ENDOCRINOLOGY
- On the Trail of the Glucocorticoid Receptor: Into the Nucleus and Back
- (2011) Sofie Vandevyver et al. TRAFFIC
- CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells
- (2010) Daniel E. Frigo et al. CANCER RESEARCH
- Chromatin-Bound Nuclear Pore Components Regulate Gene Expression in Higher Eukaryotes
- (2010) Maya Capelson et al. CELL
- Nucleoporins Directly Stimulate Expression of Developmental and Cell-Cycle Genes Inside the Nucleoplasm
- (2010) Bernike Kalverda et al. CELL
- Gene Regulation by Nucleoporins and Links to Cancer
- (2010) Alwin Köhler et al. MOLECULAR CELL
- The nuclear envelope in genome organization, expression and stability
- (2010) Karim Mekhail et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
- (2009) R. M. Attar et al. CLINICAL CANCER RESEARCH
- Oxidative Stress Inhibits Nuclear Protein Export by Multiple Mechanisms That Target FG Nucleoporins and Crm1
- (2009) Noah Crampton et al. MOLECULAR BIOLOGY OF THE CELL
- Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
- (2009) A. Gibbs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors
- (2009) Itai Kela et al. PROSTATE
- Targeting the androgen receptor pathway in prostate cancer
- (2008) Yu Chen et al. CURRENT OPINION IN PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started